Related references
Note: Only part of the references are listed.Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome
Zurina Romay-Penabad et al.
BLOOD (2011)
Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via beta 2GPI and apoER2
Sangeetha Ramesh et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies
B. de laat et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Toll-Like Receptors at the Maternal-Fetal Interface in Normal Pregnancy and Pregnancy Disorders
Kaori Koga et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2010)
Glypican-1, phosphacan/receptor protein-tyrosine phosphatase-zeta/beta and its ligand, tenascin-C, are expressed by neural stem cells and neural cells derived from embryonic stem cells
Mary Abaskharoun et al.
ASN NEURO (2010)
β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome
Cetin Agar et al.
BLOOD (2010)
Beta 2 glycoprotein I is a substrate of thiol oxidoreductases
Freda H. Passam et al.
BLOOD (2010)
The Pathogenesis of Neural Injury in Animal Models of the Antiphospholipid Syndrome
Aviva Katzav et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2010)
Role of Tissue Factor in the Maternal Immunological Attack of the Embryo in the Antiphospholipid Syndrome
Guillermina Girardi
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2010)
Effects of Polyclonal IgG Derived from Patients with Different Clinical Types of the Antiphospholipid Syndrome on Monocyte Signaling Pathways
Anastasia Lambrianides et al.
JOURNAL OF IMMUNOLOGY (2010)
TLR2 Is One of the Endothelial Receptors for β2-Glycoprotein I
Jean-Eric Alard et al.
JOURNAL OF IMMUNOLOGY (2010)
Antiphospholipid syndrome
Guillermo Ruiz-Irastorza et al.
LANCET (2010)
Domain I of β2-glycoprotein I: its role as an epitope and the potential to be developed as a specific target for the treatment of the antiphospholipid syndrome
Y. Ioannou et al.
LUPUS (2010)
Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view
P. L. Meroni et al.
LUPUS (2010)
The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis
J. H. Rand et al.
LUPUS (2010)
Reelin and apolipoprotein E receptor 2 in the embryonic and mature brain: effects of an evolutionary change in the apoER2 gene
Nicolas B. Myant
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2010)
Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity
Yao-Hsu Yang et al.
RHEUMATOLOGY (2010)
Natural Catalytic Antibodies in Norm, Autoimmune, Viral, and Bacterial Diseases
Georgy A. Nevinsky et al.
THESCIENTIFICWORLDJOURNAL (2010)
Antibodies to Serine Proteases in the Antiphospholipid Syndrome
Pojen P. Chen et al.
Current Rheumatology Reports (2010)
Impaired Fibrinolysis in the Antiphospholipid Syndrome
Katie A. Krone et al.
Current Rheumatology Reports (2010)
Antiphospholipid Antibodies Induce a Pro-Inflammatory Response in First Trimester Trophoblast Via the TLR4/MyD88 Pathway
Melissa J. Mulla et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2009)
Complement activation in patients with primary antiphospholipid syndrome
K. Oku et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo
Zurina Romay-Penabad et al.
BLOOD (2009)
Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies
Surya V. Seshan et al.
BLOOD (2009)
Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
Yehuda Shoenfeld et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Annexin A2 mediates anti-β2GPI/β2GPI-induced tissue factor expression on monocytes
Hong Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2009)
In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of β2-glycoprotein I: proof of concept
Y. Ioannou et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study
B. De Laat et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells
Xia V. Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neonatal effects of maternal antiphospholipid syndrome
Angela Tincani et al.
Current Rheumatology Reports (2009)
Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity
Pier Luigi Meroni
JOURNAL OF AUTOIMMUNITY (2008)
Platelet activation by dimeric β2-glycoprotein I requires signaling via both glycoprotein Ibα and apolipoprotein E receptor 2'
R. T. Urbanus et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Annexin A2: biology and relevance to the antiphospholipid syndrome
E. Cockrell et al.
LUPUS (2008)
Heparan sulfate proteoglycans in the basement membranes of the human placenta and decidua
C. -P. Chen et al.
PLACENTA (2008)
The truth is out there - The quest for a fibromyalgia unified concept - Reply
Manuel Martinez-Lavin
SEMINARS IN ARTHRITIS AND RHEUMATISM (2008)
Antiphospholipid antibodies and the antiphospholipid syndrome: Pathogenic mechanisms
Silvia S. Pierangeli et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
Mechanisms of Disease: antiphospholipid antibodies - from clinical association to pathologic mechanism
Bas de Laat et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody-induced fetal injury
Patricia Redecha et al.
BLOOD (2007)
Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies
Silvia S. Pierangeli et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Role of p38 mitogen-activated protein kinase in anti phospholipid anti body-mediated thrombosis and endothelial cell activation
M. E. Vega-Ostertag et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
Sung-Chun Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study
Monica Galli et al.
BLOOD (2007)
The Th1/Th2 paradigm: still important in pregnancy?
Gerard Chaouat
SEMINARS IN IMMUNOPATHOLOGY (2007)
Complement activation in anti-phospholipid syndrome: A clue for an inflammatory process?
Ilaria Cavazzana et al.
JOURNAL OF AUTOIMMUNITY (2007)
The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies
Nathalie Satta et al.
BLOOD (2007)
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6
Yeny Martinez de la Torre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Current concepts on the pathogenesis of the antiphospholipid syndrome
Bill Giannakopoulos et al.
BLOOD (2007)
A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells
Mariano Vega-Ostertag et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
Guillermina Girardi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome
Julia Francis et al.
MOLECULAR HUMAN REPRODUCTION (2006)
Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophages
Y. Wegrowski et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
A peptide that mimics the Vth region of beta(2)glycoprotein I reverses antiphospholipid-mediated thrombosis in mice
M. Vega Ostertag et al.
LUPUS (2006)
Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor
F Fischetti et al.
BLOOD (2005)
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia
SS Pierangeli et al.
ARTHRITIS AND RHEUMATISM (2005)
Evidence of Toll-like receptor molecules on human platelets
F Cognasse et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies
JW Zhang et al.
BLOOD (2005)
Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss:: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitro
N Di Simone et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice
JM Thurman et al.
MOLECULAR IMMUNOLOGY (2005)
TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss
J Berman et al.
JOURNAL OF IMMUNOLOGY (2005)
Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2
CC Chua et al.
CIRCULATION RESEARCH (2004)
Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation
G Girardi et al.
NATURE MEDICINE (2004)
Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
M Galli et al.
BLOOD (2003)
Prevalence and clinical correlations of antibodies against six β2-glycoprotein-I-related peptides in the antiphospholipid syndrome
Y Shoenfeld et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2003)
Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies
E Raschi et al.
BLOOD (2003)
E-Selectin mediates pathogenic effects of antiphospholipid antibodies
RG Espinola et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Thrombogenicity of beta(2)-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster
M Jankowski et al.
BLOOD (2003)
Complement C3 activation is required for antiphospholipid antibody-induced fetal loss
VM Holers et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Functional proteomics: Examining the effects of hypoxia on the cytotrophoblast protein repertoire
VM Hoang et al.
BIOCHEMISTRY (2001)